Paying for Precision: The Economics of Molecular Testing

KM

Kwame Mensah

Director of Health Economics, Meridian Life Sciences Society

Day 310:10 am – 10:45 amHall B (L2-HALL-B)
Part of: Precision Oncology: From Biomarker to Bedside (9:00 am – 10:45 am)

Abstract

Where molecular testing saves money, where it does not, and how payers decide which is which.

Description

Presented in “Precision Oncology: From Biomarker to Bedside”.

About the Speaker

KM

Kwame Mensah

Director of Health Economics, Meridian Life Sciences Society

View Full Profile

Q&A for Paying for Precision: The Economics of Molecular Testing

Sign in to vote on questions.

Details
Duration35 min
RoomHall B (L2-HALL-B)
Tags
#live-day#translational-medicine
This Session

Precision Oncology: From Biomarker to Bedside

9:00 am – 10:45 am

Hall B

2 talks in this session

View Session
Other Talks in This Session